FourThought Financial’s Twist Bioscience TWST Stock Holding History

FourThought Financial’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$14K	Hold	392	–	–	﹤0.01%	956
2022 Q2	$14K	Hold	392	–	–	﹤0.01%	951
2022 Q1	$19K	Buy	392 +70	+22%	+$3.88K	﹤0.01%	919
2021 Q4	$25K	Hold	322	–	–	﹤0.01%	878
2021 Q3	$34K	Buy	322 +30	+10%	+$3.44K	﹤0.01%	809
2021 Q2	$38K	Sell	292 -5	-2%	-$581	0.01%	789
2021 Q1	$36K	Sell	297 -26	-8%	-$3.95K	0.01%	769
2020 Q4	$45K	Buy	+323	New	+$35.8K	0.01%	690

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

FourThought Financial's TWST Position: Q3 2022 in Review

FourThought Financial held its Twist Bioscience (TWST) position steady in Q3 2022 at 392 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #956.

FourThought Financial first reported a position in TWST in Q4 2020 and has held it in 8 quarters since. The position peaked at $45K in Q4 2020. 222 funds tracked by Wall St. Rank hold TWST as of Q3 2022.

FourThought Financial held 392 shares of Twist Bioscience worth $14K as of Q3 2022.
FourThought Financial left its Twist Bioscience share count unchanged in Q3 2022.
Twist Bioscience made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #956 holding.
FourThought Financial first reported a position in Twist Bioscience in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's Twist Bioscience position peaked at $45K in Q4 2020.
222 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.